Literature DB >> 33914735

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.

Xing Zhu1, Dhiraj Mannar1, Shanti S Srivastava1, Alison M Berezuk1, Jean-Philippe Demers1, James W Saville1, Karoline Leopold1, Wei Li2, Dimiter S Dimitrov2, Katharine S Tuttle1, Steven Zhou1, Sagar Chittori1, Sriram Subramaniam1.   

Abstract

The recently reported "UK variant" (B.1.1.7) of SARS-CoV-2 is thought to be more infectious than previously circulating strains as a result of several changes, including the N501Y mutation. We present a 2.9-Å resolution cryo-electron microscopy (cryo-EM) structure of the complex between the ACE2 receptor and N501Y spike protein ectodomains that shows Y501 inserted into a cavity at the binding interface near Y41 of ACE2. This additional interaction provides a structural explanation for the increased ACE2 affinity of the N501Y mutant, and likely contributes to its increased infectivity. However, this mutation does not result in large structural changes, enabling important neutralization epitopes to be retained in the spike receptor binding domain. We confirmed this through biophysical assays and by determining cryo-EM structures of spike protein ectodomains bound to 2 representative potent neutralizing antibody fragments.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33914735     DOI: 10.1371/journal.pbio.3001237

Source DB:  PubMed          Journal:  PLoS Biol        ISSN: 1544-9173            Impact factor:   8.029


  71 in total

Review 1.  Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants.

Authors:  Deepali Gupta; Priyanka Sharma; Mandeep Singh; Mukesh Kumar; A S Ethayathulla; Punit Kaur
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

2.  SARS-CoV-2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice.

Authors:  Yao Ma; Ye Wang; Chunhong Dong; Gilbert X Gonzalez; Wandi Zhu; Joo Kim; Lai Wei; Sang-Moo Kang; Bao-Zhong Wang
Journal:  Small       Date:  2022-05-23       Impact factor: 15.153

3.  Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants.

Authors:  Jonathan M Labriola; Shane Miersch; Gang Chen; Chao Chen; Alevtina Pavlenco; Reza Saberianfar; Francesca Caccuri; Alberto Zani; Nitin Sharma; Annie Feng; Daisy W Leung; Arnaldo Caruso; Giuseppe Novelli; Gaya K Amarasinghe; Sachdev S Sidhu
Journal:  ACS Chem Biol       Date:  2022-06-22       Impact factor: 4.634

4.  Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNA-Vaccinated People Against Wild-Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern.

Authors:  Mandy Schwarze; Andor Krizsan; Alexandra Brakel; Fabian Pohl; Daniela Volke; Ralf Hoffmann
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

Review 5.  SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance.

Authors:  Yifei Guo; Jiajia Han; Yao Zhang; Jingjing He; Weien Yu; Xueyun Zhang; Jingwen Wu; Shenyan Zhang; Yide Kong; Yue Guo; Yanxue Lin; Jiming Zhang
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 6.  Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.

Authors:  Daniele Focosi; Fabrizio Maggi
Journal:  Rev Med Virol       Date:  2021-03-16       Impact factor: 11.043

7.  Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants.

Authors:  Amarendra Pegu; Sarah O'Connell; Stephen D Schmidt; Sijy O'Dell; Chloe A Talana; Lilin Lai; Jim Albert; Evan Anderson; Hamilton Bennett; Kizzmekia S Corbett; Britta Flach; Lisa Jackson; Brett Leav; Julie E Ledgerwood; Catherine J Luke; Mat Makowski; Paul C Roberts; Mario Roederer; Paulina A Rebolledo; Christina A Rostad; Nadine G Rouphael; Wei Shi; Lingshu Wang; Alicia T Widge; Eun Sung Yang; John H Beigel; Barney S Graham; John R Mascola; Mehul S Suthar; Adrian McDermott; Nicole A Doria-Rose
Journal:  bioRxiv       Date:  2021-05-16

8.  Structures of synthetic nanobody-SARS-CoV-2-RBD complexes reveal distinct sites of interaction and recognition of variants.

Authors:  David Margulies; Javeed Ahmad; Jiansheng Jiang; Lisa Boyd; Allison Zeher; Rick Huang; Di Xia; Kannan Natarajan
Journal:  Res Sq       Date:  2021-06-16

9.  Allosteric Cross-Talk among Spike's Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor.

Authors:  Angelo Spinello; Andrea Saltalamacchia; Jure Borišek; Alessandra Magistrato
Journal:  J Phys Chem Lett       Date:  2021-06-23       Impact factor: 6.475

10.  Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.

Authors:  Yongfei Cai; Jun Zhang; Tianshu Xiao; Christy L Lavine; Shaun Rawson; Hanqin Peng; Haisun Zhu; Krishna Anand; Pei Tong; Avneesh Gautam; Shen Lu; Sarah M Sterling; Richard M Walsh; Sophia Rits-Volloch; Jianming Lu; Duane R Wesemann; Wei Yang; Michael S Seaman; Bing Chen
Journal:  Science       Date:  2021-06-24       Impact factor: 63.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.